February 8, 2026

Background

Cristina Adriana Popa

To INFINITI and Beyond: SGLT2 Inhibitors in ...

This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.

January 26, 2026

Background

Cristina Adriana Popa

POTCAST- K+ Pop and Arrhythmia Drop

This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.

January 11, 2026

Background

Brian Rifkin

A VALIANT effort to combat complement disorders ...

This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.

January 3, 2026

news

Cristina Adriana Popa

Top Stories in Nephrology 2025

2025 was rich in successful stories. Here are the top 10 that impressed our audience.

December 15, 2025

Background

Brian Rifkin

Dialyze Less, Recover More? AKI’s Chance to Get ...

This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.

cycling

Guest User

July 5, 2021

Cycling towards better health outcomes in dialysis patients - A commentary

Guest User

July 5, 2021

Cycling towards better health outcomes in dialysis patients - A commentary

Clara Bohm and Oksana Harasemiw write an editorial commentary on the CYCLE-HD trial on behalf of the Global renal Exercise Network

Guest User

July 5, 2021

Background

Cycling Away from Cardiac Complications

Guest User

July 5, 2021

Background

As the Tour de France goes on, it is timely to discuss the role of exercise, while on dialysis. The CYCLEHD trial reported a lowering of left ventricular mass. Let’s dig deeper, as we do.